Chat with AI
Deck 16: Anticoagulant, Antiplatelet, and Fibrinolytic Drugs
Full screen (f)
Question
Question
Question
Unlock Deck
Sign up to unlock the cards in this deck!
Unlock Deck
Unlock Deck
1/3
Play
Full screen (f)
Deck 16: Anticoagulant, Antiplatelet, and Fibrinolytic Drugs
A patient receives a cyclic peptide derived from rattlesnake venom.Which step leading to platelet aggregation is inhibited by this agent?
A) glycoprotein IIb/IIIa expression
B) ADP binding
C) fibrinogen binding
D) cyclic AMP formation
E) 5-hydroxytryptamine synthesis
A) glycoprotein IIb/IIIa expression
B) ADP binding
C) fibrinogen binding
D) cyclic AMP formation
E) 5-hydroxytryptamine synthesis
fibrinogen binding
Which coagulation factor is inactivated following administration of lepirudin?
A) tissue thromboplastin
B) fibrinogen
C) prothrombin
D) active factor X
E) thrombin
A) tissue thromboplastin
B) fibrinogen
C) prothrombin
D) active factor X
E) thrombin
active factor X
Which anticoagulant consists of a synthetic antithrombin III-binding pentasaccharide?
A) fondaparinux
B) bivalirudin
C) warfarin
D) heparin
E) enoxaparin
A) fondaparinux
B) bivalirudin
C) warfarin
D) heparin
E) enoxaparin
fondaparinux
Unlock Deck
Unlock for access to all 3 flashcards in this deck.
